Assessing Immunome (IMNM) Valuation After Recent Share Price Momentum And Conflicting P/B And DCF Signals [Yahoo! Finance]
Immunome, Inc. (IMNM)
Company Research
Source: Yahoo! Finance
Immunome (IMNM) has drawn attention after a strong past 3 months, with its share price currently at $22.85 and a 1 day return of 10.07%, alongside a 1 week gain of 11.74%. Over the past month the stock shows a 2.68% decline, while the past 3 months reflect a 45.82% gain and the 1 year total return is 131.74%, highlighting sizable recent share price moves. See our latest analysis for Immunome. For Immunome, the recent 10.07% 1 day share price return and 11.74% 1 week share price return come after a 45.82% 3 month share price gain and a very large 3 year total shareholder return. This suggests that momentum has been building over a longer horizon. If this kind of move has your attention, it could be a moment to widen your watchlist and look at healthcare stocks as potential additions alongside Immunome. With Immunome trading at $22.85 alongside an analyst price target of $34.50 and an indicated intrinsic discount, you have to ask: is this a genuine mispricing, or is the marke
Show less
Read more
Impact Snapshot
Event Time:
IMNM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMNM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMNM alerts
High impacting Immunome, Inc. news events
Weekly update
A roundup of the hottest topics
IMNM
News
- Immunome (IMNM) Is Up 11.7% After Phase 3 Varegacestat Success - Has The Bull Case Changed? [Yahoo! Finance]Yahoo! Finance
- Is Immunome, Inc. (IMNM) The Best Booming Stock To Buy Right Now? [Yahoo! Finance]Yahoo! Finance
- Immunome (NASDAQ:IMNM) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $31.00 price target on the stock.MarketBeat
- Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- Jim Cramer on Immunome: “If You Want to Speculate on It, Fine” [Yahoo! Finance]Yahoo! Finance
IMNM
Earnings
- 8/6/25 - Beat
IMNM
Sec Filings
- 12/30/25 - Form 4
- 12/23/25 - Form 4
- 12/22/25 - Form SCHEDULE
- IMNM's page on the SEC website